Works matching IS 13524585 AND DT 2022 AND VI 28 AND IP 13


Results: 22
    1
    2
    3
    4
    5
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16

    Breakthrough SARS-CoV-2 infections in MS patients on disease-modifying therapies.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2106, doi. 10.1177/13524585221102918
    By:
    • Schiavetti, Irene;
    • Cordioli, Cinzia;
    • Stromillo, Maria Laura;
    • Teresa Ferrò, Maria;
    • Laroni, Alice;
    • Cocco, Eleonora;
    • Cola, Gaia;
    • Pasquali, Livia;
    • Rilla, Maria Teresa;
    • Signoriello, Elisabetta;
    • Iodice, Rosa;
    • Di Sapio, Alessia;
    • Lanzillo, Roberta;
    • Caleri, Francesca;
    • Annovazzi, Pietro;
    • Conte, Antonella;
    • Liberatore, Giuseppe;
    • Ruscica, Francesca;
    • Docimo, Renato;
    • Bonavita, Simona
    Publication type:
    Article
    17
    18
    19
    20
    21

    Natalizumab treatment and pregnancy in multiple sclerosis: A reappraisal of maternal and infant outcomes after 6 years.

    Published in:
    Multiple Sclerosis Journal, 2022, v. 28, n. 13, p. 2137, doi. 10.1177/13524585221079598
    By:
    • Portaccio, Emilio;
    • Pastò, Luisa;
    • Razzolini, Lorenzo;
    • Moiola, Lucia;
    • Martinelli, Vittorio;
    • Annovazzi, Pietro;
    • Ghezzi, Angelo;
    • Zaffaroni, Mauro;
    • Lanzillo, Roberta;
    • Brescia Morra, Vincenzo;
    • Rinaldi, Francesca;
    • Gallo, Paolo;
    • Gasperini, Claudio;
    • Paolicelli, Damiano;
    • Simone, Marta;
    • Pozzilli, Carlo;
    • De Giglio, Laura;
    • Cavalla, Paola;
    • Cocco, Eleonora;
    • Marrosu, Maria Giovanna
    Publication type:
    Article
    22